The company, which makes dicamba-based herbicide XtendiMax, is confident approval could come in the fourth quarter and hopeful a decision could be made as soon as the end of the month,
Dicamba’s approval would come after the
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
